Menu
Recruiting NCT06536946

B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers

Observational Cutaneous Squamous Cell Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Immunohistochemical staining.
Who it may be relevant to
Registry conditions: Cutaneous Squamous Cell Carcinoma. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Expression of B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers

Overview

Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it

Detailed description

Skin cancer is one of the most common form of cancer worldwide. Cutaneous squamous cell carcinoma is one of most common skin tumers that caused by many factors as ultra violet ,ionizing radiation and others . It was an advanced spectrum ranging from actinic keratosis to invasive and metastatic squmous cell carcinoma. Correct identification of cutaneous squamous cell carcinoma is a challenge as it has both clinically and histopathologically mimickers.

So the aim of this study is to identify the expression of B-catenin in cutaneous Squamous cell carcinoma and its mimickers.

Interventions

  • Biological Immunohistochemical staining
    Staining of cutanous squamous cell carcinoma and its mimickers by monoclonal antibodies against human B-catenin by immunohistochemical procedures

Primary outcome measures

  • Detection of B-catenin expression in cutanous squamous cell carcinoma and its mimickers [Time frame: 6 month]

Eligibility criteria

Inclusion criteria

  • tissue blocks with sufficient materials Cases with sufficient data

Exclusion criteria

  • tissue blocks with insufficient and necrotic materials. Casas with insufficient data

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Egypt · 1 center
  • Sohag University hospital — Sohag

Identifiers

NCT: NCT06536946 · Soh-Med-25-05-07MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗